The separation depends on the interaction between peptide hydrophobic regions and the C18 silica surface. These hydrophobic chains retain peptides and other analytes, whereas salts and other small, polar contaminants remain associated with the aqueous phase and are removed during washing. This difference in chemical behavior allows the target sample to remain on the material while unwanted components are discarded.
Aqueous washes selectively carry away salts and other small, polar contaminants while the retained peptides remain associated with the hydrophobic C18 surface. Removing these substances before elution reduces the burden of interfering components in the recovered sample. The resulting cleanup is especially important when the sample will undergo chromatographic or mass spectrometric analysis.
By removing salts and concentrating the retained sample, C18 desalting creates conditions that support more effective ionization and cleaner spectral measurements. Improved spectral quality can make peptide and protein signals easier to interpret, supporting reliable protein identification and quantitative comparisons. This benefit connects the preparation step directly to the quality of downstream analytical results.
A typical workflow retains the peptide or protein solution on reversed-phase C18 silica, washes the material with an aqueous solution to remove salts and other small polar contaminants, and then elutes the retained sample with an organic solvent. Acidified acetonitrile is often used for elution. This sequence both cleans and concentrates the material for subsequent analysis.
Reversed-phase C18 silica provides the hydrophobic surface that retains peptides and other analytes. Aqueous solutions serve as the washing environment, allowing salts and small polar contaminants to be carried away. An organic solvent, often acidified acetonitrile, releases the retained material during elution. Together, these components create the cleanup and concentration sequence.
In cancer research, the method is useful before proteomic measurements, biomarker discovery, and analysis of tumor-associated peptides. Cleaner, more concentrated samples can support protein identification, quantitative comparisons, and downstream characterization of cancer-related molecular changes. Its value lies in strengthening the analytical quality of samples used to investigate molecular differences associated with tumors.